After these initial reports, associations with asthma, COPD, liver fibrosis, and cancer have indicated a role for YKL-40 in inflammation and tissue remodeling, but the exact biological activities are yet to be identified [1]. This evidence concerns the gene CHI3L1 and chronic obstructive pulmonary disease.